Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026)
Repligen (RGEN) reported Other Non-Current Liabilities of $778000.0 for Q1 2026, down 84.13% year-over-year from $4.9 million in Q1 2025, and down 87.75% quarter-over-quarter from $6.4 million in Q4 2025.
Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has 16 years of Other Non-Current Liabilities data on file, last reported at $778000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $778000.0, down 84.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $778000.0 (down 84.13% YoY), and the FY2025 annual result was $6.4 million, down 67.69% from the prior year.
- Other Non-Current Liabilities retreated to $778000.0 in Q1 2026 per RGEN's latest filing, from $6.4 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $69.1 million in Q3 2022 and troughed at $778000.0 in Q1 2026.
- A 5-year average of $20.0 million and a median of $11.3 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities surged 4515.7% in 2022, then slumped 84.13% in 2026.
- A 5-year view of Other Non-Current Liabilities shows it stood at $10.8 million in 2022, then increased by 4.9% to $11.3 million in 2023, then soared by 74.26% to $19.7 million in 2024, then plunged by 67.69% to $6.4 million in 2025, then slumped by 87.75% to $778000.0 in 2026.
- Business Quant data shows RGEN's Other Non-Current Liabilities at $778000.0 in Q1 2026, $6.4 million in Q4 2025, and $17.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 778,000.00 |
| Dec 31, 2025 | 6.35 Mn |
| Sep 30, 2025 | 17.32 Mn |
| Jun 30, 2025 | 6.66 Mn |
| Mar 31, 2025 | 4.90 Mn |
| Dec 31, 2024 | 19.66 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 11.28 Mn |
| Sep 30, 2023 | 11.15 Mn |
| Jun 30, 2023 | 44.28 Mn |
| Mar 31, 2023 | 15.71 Mn |
| Dec 31, 2022 | 10.76 Mn |
| Sep 30, 2022 | 69.14 Mn |
| Jun 30, 2022 | 67.90 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 79.96 Mn |
| Jun 30, 2021 | 1.47 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | 1.32 Mn |